Published in Proc Natl Acad Sci U S A on August 16, 2004
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A (2009) 5.86
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A (2006) 5.19
Food-borne trematodiases. Clin Microbiol Rev (2009) 3.08
Host-parasite interactions revealed by Plasmodium falciparum metabolomics. Cell Host Microbe (2009) 2.00
Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol (2006) 1.99
Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc Natl Acad Sci U S A (2008) 1.24
Environmental exposure measurement in cancer epidemiology. Mutagenesis (2008) 1.19
Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology (2010) 1.16
Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride. Proc Natl Acad Sci U S A (2009) 1.15
Eating at the table of another: metabolomics of host-parasite interactions. Cell Host Microbe (2010) 1.08
Discovery of metabolite features for the modelling and analysis of high-resolution NMR spectra. Int J Data Min Bioinform (2008) 1.04
The application of NMR-based metabonomics in neurological disorders. NeuroRx (2006) 1.03
Metabolic profiling of an Echinostoma caproni infection in the mouse for biomarker discovery. PLoS Negl Trop Dis (2008) 1.03
Fatty acid oxidation is essential for egg production by the parasitic flatworm Schistosoma mansoni. PLoS Pathog (2012) 1.01
The nutritional phenotype in the age of metabolomics. J Nutr (2005) 0.96
Interactions between parasites and microbial communities in the human gut. Front Cell Infect Microbiol (2012) 0.95
Differential liver protein expression during schistosomiasis. Infect Immun (2006) 0.95
Integrated cytokine and metabolic analysis of pathological responses to parasite exposure in rodents. J Proteome Res (2010) 0.95
Recent advances of metabolomics in plant biotechnology. Plant Biotechnol Rep (2011) 0.93
Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl Trop Dis (2010) 0.92
A loop-mediated isothermal amplification (LAMP) assay for early detection of Schistosoma mansoni in stool samples: a diagnostic approach in a murine model. PLoS Negl Trop Dis (2014) 0.92
The newest "omics"--metagenomics and metabolomics--enter the battle against the neglected tropical diseases. PLoS Negl Trop Dis (2015) 0.90
Alterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression. Malar J (2010) 0.90
Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse. J Proteome Res (2009) 0.89
Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance. J Biomed Biotechnol (2010) 0.86
Co-ordinated gene expression in the liver and spleen during Schistosoma japonicum infection regulates cell migration. PLoS Negl Trop Dis (2010) 0.85
Metabolic changes reveal the development of schistosomiasis in mice. PLoS Negl Trop Dis (2010) 0.85
Advances in the Diagnosis of Human Schistosomiasis. Clin Microbiol Rev (2015) 0.84
H NMR spectroscopy-based metabolomic assessment of uremic toxicity, with toxicological outcomes, in male rats following an acute, mid-life insult from ochratoxin a. Toxins (Basel) (2011) 0.82
Chemometric analysis of biofluids from mice experimentally infected with Schistosoma mansoni. Parasit Vectors (2011) 0.81
Transcriptomic profiling of host-parasite interactions in the microsporidian Trachipleistophora hominis. BMC Genomics (2015) 0.81
Biomarker discovery in animal health and disease: the application of post-genomic technologies. Biomark Insights (2007) 0.81
Metabolic response to Klebsiella pneumoniae infection in an experimental rat model. PLoS One (2012) 0.81
Carboxylic acids as biomarkers of Biomphalaria alexandrina snails infected with Schistosoma mansoni. Korean J Parasitol (2010) 0.81
LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case. Comput Struct Biotechnol J (2013) 0.81
High performance thin layer chromatographic analysis of neutral lipids in the urine of BALB/c mice infected with Echinostoma caproni. Parasitol Res (2007) 0.79
(13)C heteronuclear NMR studies of the interaction of cultured neurons and astrocytes and aluminum blockade of the preferential release of citrate from astrocytes. J Biol Inorg Chem (2007) 0.79
Longitudinal analysis of antigen specific response in individuals with Schistosoma mansoni infection in an endemic area of Minas Gerais, Brazil. Trans R Soc Trop Med Hyg (2013) 0.78
Metabonomic investigation of single and multiple strain Trypanosoma brucei brucei infections. Am J Trop Med Hyg (2011) 0.78
The use of high-resolution ¹H nuclear magnetic resonance (NMR) spectroscopy in the clinical diagnosis of Acanthamoeba. Parasitol Res (2011) 0.78
Structure and functional characterization of a bile acid 7α dehydratase BaiE in secondary bile acid synthesis. Proteins (2016) 0.78
A serum metabolomic investigation on lipoprotein lipase-deficient mice with hyperlipidemic pancreatitis using gas chromatography/mass spectrometry. Biomed Rep (2013) 0.77
The metabolic control of schistosome egg production. Cell Microbiol (2015) 0.77
Metabolomic profiling of faecal extracts from Cryptosporidium parvum infection in experimental mouse models. PLoS One (2013) 0.76
Antischistosomal Activity of Two Active Constituents Isolated from the Leaves of Egyptian Medicinal Plants. Infect Dis (Auckl) (2015) 0.76
1H NMR metabonomics indicates continued metabolic changes and sexual dimorphism post-parasite clearance in self-limiting murine malaria model. PLoS One (2013) 0.75
Development of "-omics" research in Schistosoma spp. and -omics-based new diagnostic tools for schistosomiasis. Front Microbiol (2014) 0.75
Genetic algorithm-based feature selection in high-resolution NMR spectra. Expert Syst Appl (2008) 0.75
The influence of trematode parasite burden on gene expression in a mammalian host. BMC Genomics (2016) 0.75
Diagnosis of coinfection by schistosomiasis and viral hepatitis B or C using 1H NMR-based metabonomics. PLoS One (2017) 0.75
(1)H NMR and MVA metabolomic profiles of urines from piglets fed with boluses contaminated with a mixture of five mycotoxins. Biochem Biophys Rep (2017) 0.75
Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser (2002) 14.79
A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science (2003) 12.57
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 9.04
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop (2003) 6.64
Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov (2003) 4.46
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem (1995) 3.61
Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother (2004) 2.75
Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology (2001) 2.34
Underestimation of Schistosoma mansoni prevalences. Parasitol Today (1992) 2.23
A novel and accurate diagnostic test for human African trypanosomiasis. Lancet (2004) 2.22
Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol (2004) 2.13
An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett (2000) 1.74
Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol (2004) 1.66
Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol (2000) 1.49
Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem (2003) 1.42
NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol (2003) 1.42
Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett (2002) 1.39
The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop (2003) 1.30
Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem (2003) 1.24
IN VITRO CULTIVATION OF SCHISTOSOMA MANSONI. Exp Parasitol (1965) 1.21
Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol (2001) 1.20
Metabolism and excretion of methylamines in rats. Toxicol Appl Pharmacol (1994) 1.19
The use of ultrasound in schistosomiasis. Adv Parasitol (2001) 1.14
Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed (1998) 1.05
Comparative study of normal and osteoarthritic canine synovial fluid using 500 MHz 1H magnetic resonance spectroscopy. J Orthop Res (1999) 1.04
Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop (2000) 1.04
Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal Biochem (2001) 1.03
Trimethylamine oxide accumulation in marine animals: relationship to acylglycerol storage. J Exp Biol (2002) 1.03
Gut flora and the origin of some urinary aromatic phenolic compounds. Biochem Pharmacol (1994) 1.00
Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol Pharmacol (1985) 1.00
Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol (1991) 0.97
Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats. Chem Res Toxicol (2003) 0.93
Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans R Soc Trop Med Hyg (2002) 0.90
A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study. Biomarkers (2000) 0.89
Schistosoma mansoni: utilization of exogenous metabolites by eggs in vitro. Exp Parasitol (1974) 0.86
Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: responses to citrate. J Urol (1991) 0.84
Different levels of Schistosoma mansoni infection induce changes in drug-metabolizing enzymes. J Helminthol (1998) 0.83
In vivo toxicity screening programs using metabonomics. Comb Chem High Throughput Screen (2002) 0.83
Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers. Arzneimittelforschung (1995) 0.82
Tryptophan metabolism and vitamin B6 nutritional status in patients with schistosomiasis mansoni and in infected mice. Parasitology (1992) 0.81
Response from Jeffrey I. Gordon et al.: Commensal bacteria make a difference. Trends Microbiol (2003) 0.81
Diagnostic value of serum lactate dehydrogenase isoenzyme and amino acid patterns in several schistosomal and non-schistosomal disorders as compared to other biochemical parameters. Dis Markers (1996) 0.81
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis (2006) 13.74
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Host-gut microbiota metabolic interactions. Science (2012) 7.73
Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science (2013) 6.98
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA (2008) 6.57
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov (2002) 5.96
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc (2007) 5.92
Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 5.41
Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol (2005) 5.35
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Systems biology: Metabonomics. Nature (2008) 5.32
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A (2006) 5.19
Urbanization in sub-saharan Africa and implication for malaria control. Am J Trop Med Hyg (2004) 5.07
Identification of an antimalarial synthetic trioxolane drug development candidate. Nature (2004) 4.57
Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med (2009) 4.49
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med (2008) 4.35
Emerging foodborne trematodiasis. Emerg Infect Dis (2005) 4.34
Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem (2005) 4.14
Chemometrics in metabonomics. J Proteome Res (2007) 4.02
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
Factors affecting home delivery in rural Tanzania. Trop Med Int Health (2007) 3.91
Sustainable schistosomiasis control--the way forward. Lancet (2003) 3.86
Effect of sanitation on soil-transmitted helminth infection: systematic review and meta-analysis. PLoS Med (2012) 3.82
Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet (2005) 3.79
A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol (2007) 3.68
The public health significance and control of schistosomiasis in China--then and now. Acta Trop (2005) 3.65
Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis (2011) 3.52
Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med (2014) 3.50
Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Past, present, and future of Japanese encephalitis. Emerg Infect Dis (2009) 3.40
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis (2008) 3.31
Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol (2009) 3.27
Strengthening capacity for health research in Africa. Lancet (2008) 3.27
Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci Transl Med (2013) 3.26
Diagnosis of soil-transmitted helminths in the era of preventive chemotherapy: effect of multiple stool sampling and use of different diagnostic techniques. PLoS Negl Trop Dis (2008) 3.26
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci U S A (2011) 3.23
Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysis. Lancet Infect Dis (2013) 3.23
A blueprint for success: integration of neglected tropical disease control programmes. Trends Parasitol (2006) 3.10
Food-borne trematodiases. Clin Microbiol Rev (2009) 3.08
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
Positive health: connecting well-being with biology. Philos Trans R Soc Lond B Biol Sci (2004) 2.95
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med (2006) 2.95
The use of antenatal and postnatal care: perspectives and experiences of women and health care providers in rural southern Tanzania. BMC Pregnancy Childbirth (2009) 2.95
Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 2.90
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One (2010) 2.90
Potential impact of climate change on schistosomiasis transmission in China. Am J Trop Med Hyg (2008) 2.87
Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania. PLoS One (2009) 2.85
Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol (2004) 2.84
Health and survival of young children in southern Tanzania. BMC Public Health (2008) 2.83
Integrated urban malaria control: a case study in dar es salaam, Tanzania. Am J Trop Med Hyg (2004) 2.80
Metabolic phenotyping in health and disease. Cell (2008) 2.80
Time to set the agenda for schistosomiasis elimination. Acta Trop (2012) 2.79
Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol (2002) 2.78
A tool box for operational mosquito larval control: preliminary results and early lessons from the Urban Malaria Control Programme in Dar es Salaam, Tanzania. Malar J (2008) 2.70
Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov (2008) 2.59
Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic review. Lancet Infect Dis (2005) 2.58
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J (2007) 2.57
Malaria risk on the Amazon frontier. Proc Natl Acad Sci U S A (2006) 2.55
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis. PLoS Negl Trop Dis (2012) 2.54
The use of personal digital assistants for data entry at the point of collection in a large household survey in southern Tanzania. Emerg Themes Epidemiol (2007) 2.53
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A (2010) 2.52
Social relationships, gender, and allostatic load across two age cohorts. Psychosom Med (2002) 2.51
Comparing diagnostic accuracy of Kato-Katz, Koga agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PLoS Negl Trop Dis (2010) 2.48
Gut microbiome-host interactions in health and disease. Genome Med (2011) 2.48
Mosquito nets and the poor: can social marketing redress inequities in access? Trop Med Int Health (2004) 2.44
Effect of irrigation and large dams on the burden of malaria on a global and regional scale. Am J Trop Med Hyg (2005) 2.43